Quick answer
How is CJC-1295 (No DAC) reconstituted and stored in the lab? Hold the sealed lyophilized vial at 2–8 °C, or at −20 °C when it will not be used soon, away from heat, moisture and light. Bring the vial to room temperature, wipe the stopper, let a sterile aqueous diluent trickle down the glass wall, and roll the vial gently until no particles remain; do not shake or vortex a 29-residue peptide. Use bacteriostatic water for a stock that will be entered repeatedly and unpreserved sterile water for a stock that is aliquoted and frozen at once. Refrigerate solutions, freeze single-use aliquots instead of refreezing one vial, and take concentration figures from the reconstitution calculator.
CJC-1295 without DAC, also catalogued as Modified GRF (1-29), is a synthetic analog of growth-hormone-releasing hormone used in receptor and signaling studies. Its handling is shaped by its length, its net positive charge and the substitutions that distinguish it from the native fragment. This guide explains the reasoning behind solvent choice, storage tiers, freeze–thaw limits, visual checks and records for the CJC-1295 (No DAC) vial. It is intended for in vitro and preclinical work; the material is for laboratory research use only and not for human consumption.
What is in the CJC-1295 (No DAC) vial
The compound is a single 29-amino-acid peptide supplied freeze-dried. "No DAC" means it lacks the Drug Affinity Complex, the lysine-linked group that allows the DAC version to bind albumin. The biology is summarized in the CJC-1295 (No DAC) research overview, and the difference between the two forms in CJC-1295 DAC vs No DAC.
| Property | As listed on the product page | Why it matters at the bench |
|---|---|---|
| Sequence | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-Ser-Arg | The reference for identity on the certificate |
| Molecular formula | C152H252N44O42 | Basis for molar conversions |
| Length and class | 29-amino-acid GHRH analog | Long enough to form secondary structure, foam and self-associate |
| Vial sizes | 5 mg and 10 mg | The two sizes give different concentrations for the same diluent volume, so the label has to say which was used |
| Purity specification | ≥98% (HPLC) | Chromatographic purity; distinct from net peptide content |
| Supplied form | Lyophilized powder in a sealed clear glass vial | Clear glass means the box provides the light protection |
| Storage line | Refrigerate at 2–8 °C; −20 °C for long-term; protect from heat, moisture and light | Defines the storage tiers below |
The dry material is normally a white to off-white cake or a fine powder at the bottom of the vial. A thin film on the wall, a cake that has collapsed to one side or a few loose flakes are ordinary consequences of freeze-drying and transport; the process itself is described in what is lyophilization. Before opening, match the label lot number to the document in the COA library, where one is published, and check it against the points in how to read a COA.
Chemistry that shapes handling of this peptide
Substitutions that remove known weak points
Native GHRH(1-29) has several positions that degrade readily. Plasma enzymes cut it after the second residue, a route described by Frohman and colleagues in 1986, and the native sequence also contains a methionine and an asparagine that are chemically labile. The analog on the product page carries D-alanine at position 2, glutamine at position 8, alanine at position 15 and norleucine (Nle) at position 27. Two of those matter for storage chemistry. Norleucine is a straight-chain residue without sulfur, so the methionine-sulfoxide pathway that affects many peptides is absent. Glutamine in place of asparagine removes the fastest deamidation site, because glutamine deamidates far more slowly than asparagine under comparable conditions.
What still deserves care
- Two aspartic acid residues. The sequence has Asp at positions 3 and 25, followed by alanine and isoleucine. Neither is the Asp-Gly motif that isomerizes fastest, but aspartyl residues can still isomerize or undergo backbone cleavage slowly in solution, particularly under acidic conditions and with warmth.
- Three glutamines. Slow deamidation remains possible over long storage in solution, which is one more reason not to keep liquid stocks longer than the work needs.
- Two tyrosines. Tyrosine is an aromatic, light-absorbing side chain. It makes the peptide measurable by UV absorbance and is also a reason to keep solutions out of strong light.
- No cysteine, methionine or tryptophan. There are no disulfides to scramble and no thioether or indole to oxidize.
- Net positive charge. Three arginines and two lysines outweigh the two aspartates near neutral pH. Cationic peptides dissolve well in water but bind to glass and some plastics at low concentration.
- Hydrophobic stretches. The leucine- and isoleucine-rich C-terminal half is the kind of segment that gathers at air–water interfaces. Agitation creates more interface, which is why foaming and hard vortexing are avoided.
Terminus and counterion
The product page gives the sequence but not the form of the C-terminus or the counterion. Synthetic peptides are commonly isolated as acetate or trifluoroacetate salts, and the salt and residual water both count toward the weighed mass. The certificate of analysis, where published, is the document to consult before converting mass to moles; these details should not be inferred from the name.
Solvent choice reasoning
The peptide is water-soluble, so the question is how the stock will be used after it dissolves. See bacteriostatic water explained for the general comparison.
| Diluent | When labs choose it | Strength | Limitation |
|---|---|---|---|
| Bacteriostatic water (0.9% benzyl alcohol) | A refrigerated stock entered through the stopper over several sessions | Preservative inhibits growth of most bacteria introduced between entries | Benzyl alcohol is carried into the assay and has been reported to promote aggregation of some proteins; pituitary cell models need a matched vehicle control |
| Sterile water, no preservative | A stock aliquoted and frozen the same day, or used at once | Nothing added; cleanest background for cAMP and binding assays | No growth inhibition, so unsuitable as a multi-entry refrigerated vial |
| Buffered saline or assay medium | Final working dilutions | Correct pH and ionic strength for cells | Salts encourage self-association at stock concentration; phosphate buffers shift pH on freezing |
| Dilute acetic acid | Only if a lot is slow to dissolve in water | Raises the charge on a basic peptide and aids wetting | Acid favors aspartyl degradation over time; not a storage medium |
| DMSO or other organic co-solvent | Rarely justified | Rescues strongly hydrophobic sequences | Unnecessary for this sequence and adds an assay variable |
Reconstitution workflow without the arithmetic
Volumes are omitted on purpose. With two vial sizes it is safer to choose the target concentration first and let the calculator return the diluent volume for the size in hand. The general technique is in how to reconstitute a lyophilized peptide.
- Warm the sealed vial. Opening a cold vial pulls room humidity onto the cake as condensation.
- Confirm the vial size. Read 5 mg or 10 mg from the label, not from memory, and note it in the record before calculating.
- Clean the stoppers. Wipe with an alcohol swab and allow the surface to dry before each puncture, as the product page advises.
- Add diluent slowly. Let it trickle down the inner wall so the powder wets from the edge.
- Wait, then roll. Give the powder time to wet, then roll the vial between the fingers until no particles remain. Avoid shaking or high-speed vortexing.
- Inspect and label. Confirm a clear, colorless solution and write the label before the vial leaves the bench.
- Store or aliquot. Refrigerate a preserved stock; divide and freeze an unpreserved one.
Storage tiers for lyophilized and reconstituted material
These tiers apply the product page's storage line together with the general practice in storing research peptides. They indicate where material belongs; they are not validated expiry periods for a given lot.
| State | Temperature tier | Handling notes |
|---|---|---|
| Lyophilized, on arrival and in near-term use | 2–8 °C | Sealed and boxed, on an interior shelf |
| Lyophilized, not needed soon | −20 °C | Sealed and boxed; equilibrate before opening |
| Lyophilized, ambient | Transit and brief bench time only | Return to cold storage promptly; avoid sunlight and warm surfaces |
| Solution in bacteriostatic water | 2–8 °C | Multi-entry stock; the 28-day convention for preserved multi-use containers is a common outer limit for the container and is not a measured stability figure for the peptide |
| Solution in sterile water | Frozen single-use aliquots | Divide promptly; thaw each tube once |
| Working dilution in buffer or medium | Made fresh | Use the same day and discard the remainder |
For the reasoning behind solution lifetimes and why sources disagree, see how long do reconstituted peptides last.
Freeze–thaw cycles and aliquoting
When an aqueous peptide solution freezes, pure ice separates first and everything else is pushed into a shrinking liquid fraction. Peptide and salt concentrations rise sharply in that fraction, some buffer species crystallize and move the pH, and the peptide is exposed to a large ice–liquid surface. A peptide of this length with hydrophobic segments can self-associate under those conditions, and aggregates do not always redissolve on thawing. One cycle is the accepted price of frozen storage; each further cycle adds an uncontrolled variable.
- Size aliquots to a single experiment, with a small allowance for pipetting loss.
- Use low-binding tubes and fill them reasonably full to limit headspace.
- Thaw cold, in the refrigerator or on ice, and mix by gentle inversion.
- Store in a manual-defrost freezer where possible.
- Do not refreeze the multi-entry vial; the product page's own guidance is to freeze single-use aliquots instead.
Light, moisture and adsorption
Moisture is the principal threat to the dry cake. Freeze-dried peptides are hygroscopic, and absorbed water restores enough molecular mobility for hydrolysis and isomerization to proceed in the solid. A vial that has been punctured or opened should be reconstituted, not put back as a dry vial. Light matters mainly once the peptide is in solution, where the tyrosine residues can absorb it; the clear glass vial offers no barrier, so keep it boxed.
Surface loss is easy to overlook. Published work on cationic peptides shows that a large share of a dilute solution can end up on the walls of glass or standard polypropylene containers, and that the share lost depends on the container material and the concentration. Keep stocks concentrated, prepare dilute working solutions immediately before use, avoid serial transfers through many tubes, and use the same plasticware across an experiment so that any loss is at least consistent.
Visual QC checks before each use
- Clarity. A properly dissolved solution is clear and colorless. Persistent haze or opalescence points to incomplete dissolution or aggregation; see cloudy peptide vial after reconstitution.
- Particulates. Inspect against light and dark backgrounds. Gel-like strands, flakes or fibres are discard criteria.
- Foam. A stable foam layer means the vial was agitated too hard. Let it settle; do not try to mix it back in.
- Color. Any yellowing is abnormal for this peptide.
- Closure. Look for stopper fragments in the liquid and for a loose crimp.
Appearance only screens for gross failure. Identity and purity are analytical questions, addressed in how CJC-1295 (No DAC) purity is tested.
Records and labelling
- Compound name written in full, including "No DAC", so it cannot be confused with the DAC form or with a blend.
- Vial size (5 mg or 10 mg), lot number and date received.
- Reconstitution date, diluent type and diluent lot.
- Resulting concentration and how it was calculated.
- Storage location, each entry into a multi-use vial, and thaw count for aliquots.
- Appearance at preparation and at each use, preparer initials and planned discard date.
File the certificate, where published, with the receiving record. Supplier evaluation is a separate topic covered in where to buy CJC-1295 (No DAC).
What not to do
| Practice to avoid | Why it is a problem | Better practice |
|---|---|---|
| Shaking or hard vortexing | Creates foam and air–water interface where the peptide can aggregate | Roll or swirl gently |
| Opening a cold vial | Condensation wets a hygroscopic cake | Equilibrate to room temperature first |
| Assuming the vial size | The two sizes give different concentrations from the same volume | Read the label and record it |
| Keeping an unpreserved solution as a refrigerated multi-entry stock | No inhibition of microbial growth | Aliquot and freeze, or use a preserved diluent |
| Storing stock in saline or medium | Salts promote self-association; pH shifts on freezing | Store in water; dilute into buffer at time of use |
| Refreezing one vial repeatedly | Cumulative, untracked stress | Single-use aliquots |
| Holding very dilute solutions in ordinary tubes | Cationic peptide adsorbs to the walls | Dilute just before use; low-binding plastic |
| Leaving acidified solutions for storage | Acid favors aspartyl degradation | Use acid only as a brief dissolution aid, if at all |
What stability data is and is not published
The degradation routes relevant to this sequence are well described in general terms. Reviews of peptide and protein stability cover deamidation, aspartyl isomerization, aggregation, freezing stress and adsorption, and the enzymatic cleavage of native GHRH that motivated the position 2 substitution is documented in the primary literature. What the product page does not provide is a real-time or accelerated stability study of this specific material, dry or in solution, and no shelf-life number, half-life or percentage-remaining figure is given here. Enzymatic stability in plasma is also a different property from chemical stability in a vial and should not be read across. A lab that needs a figure for its own diluent and temperature can retain an aliquot and repeat the HPLC measurement at intervals against the initial chromatogram.
Summary
CJC-1295 (No DAC) is a 29-residue, positively charged peptide whose sequence already lacks methionine, cysteine and tryptophan. The remaining risks are physical as much as chemical: moisture on the dry cake, foaming and aggregation during dissolution, adsorption at low concentration and repeated freezing. Store the dry vial cold and boxed, open it warm, dissolve it gently in a sterile aqueous diluent matched to the intended use, aliquot instead of refreezing, inspect it every time and keep a label that states the vial size and concentration.
References
- Jetté L, Léger R, Thibaudeau K, et al. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. 2005;146(7):3052-3058. doi:10.1210/en.2004-1286
- Frohman LA, Downs TR, Williams TC, Heimer EP, Pan YC, Felix AM. Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus. J Clin Invest. 1986;78(4):906-913. doi:10.1172/JCI112679
- Geiger T, Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J Biol Chem. 1987;262(2):785-794. doi:10.1016/S0021-9258(19)75855-4
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
- Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185(2):129-188. doi:10.1016/S0378-5173(99)00152-0
- Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of protein stabilization. Pharm Dev Technol. 2007;12(5):505-523. doi:10.1080/10837450701481157
- Kristensen K, Henriksen JR, Andresen TL. Adsorption of cationic peptides to solid surfaces of glass and plastic. PLoS One. 2015;10(5):e0122419. doi:10.1371/journal.pone.0122419
- Roy S, Jung R, Kerwin BA, Randolph TW, Carpenter JF. Effects of benzyl alcohol on aggregation of recombinant human interleukin-1-receptor antagonist in reconstituted lyophilized formulations. J Pharm Sci. 2005;94(2):382-396. doi:10.1002/jps.20258
Frequently Asked Questions
What does lyophilized CJC-1295 (No DAC) look like?
A white to off-white freeze-dried cake or fine powder in a sealed clear glass vial. A cake that has collapsed, cracked or moved to one side during transport is a normal cosmetic variation.
Which diluent is used for CJC-1295 (No DAC), bacteriostatic water or sterile water?
Either can dissolve it. Bacteriostatic water, with 0.9% benzyl alcohol, suits a refrigerated stock that is entered several times. Unpreserved sterile water suits a stock that is aliquoted and frozen straight away, and avoids carrying benzyl alcohol into sensitive cell assays.
Why should the vial not be shaken?
A 29-residue peptide with hydrophobic segments collects at air–water interfaces. Shaking and hard vortexing create foam and more interface, which encourages aggregation. Gentle rolling or swirling dissolves the powder without that stress.
How should unopened CJC-1295 (No DAC) be stored?
The product page states refrigeration at 2–8 °C, with −20 °C for long-term storage, protected from heat, moisture and light. Keep the vial sealed and in its box.
Does CJC-1295 (No DAC) contain methionine?
No. The sequence on the product page has norleucine at position 27, a sulfur-free residue, so methionine oxidation is not a degradation route for this analog. It also contains no cysteine or tryptophan.
Is deamidation a concern for this peptide?
Less than for native GHRH(1-29), because glutamine replaces asparagine at position 8 and glutamine deamidates much more slowly. The sequence still has three glutamines and two aspartic acids, so slow change during long storage in solution cannot be excluded.
How is the concentration calculated for the 5 mg and 10 mg vials?
Concentration is the vial mass divided by the diluent volume added. Because the two sizes give different results for the same volume, read the size from the label and use the reconstitution calculator for the arithmetic.
How many freeze–thaw cycles are acceptable?
Plan for one per aliquot. No cycle-by-cycle data for this material is published on the product page, so single-use aliquots are the conservative practice, and a tube that must be thawed twice should be marked.
What does a cloudy solution mean?
Persistent haze after gentle mixing suggests incomplete dissolution, aggregation or contamination. A solution that does not clear, or that contains strands or particles, should not be used for experiments.
Is there published shelf-life data for reconstituted CJC-1295 (No DAC)?
The product page does not publish a solution stability study. Laboratories often use the 28-day convention for preserved multi-use containers as an outer limit for the container and confirm peptide integrity by HPLC when a study depends on it.
Why does the label need to say No DAC?
The DAC and No DAC forms are different molecules with different masses and behavior in assays. Writing the full name, vial size and lot on every container prevents a mix-up between them or with a blend.
